Skip to main content

Research gives hope to premature babies and adult Crohn's patients

Babies who arrive from eight to twelve weeks early and adults who suffer from Crohn's disease are both at risk for developing short bowel syndrome, a condition that may tie them to an IV for feeding and greatly reduce the quality of their lives --medically, economically, and socially.

Now research in Kelly Tappenden's laboratory at the University of Illinois at Urbana-Champaign offers hope to patients who have had parts of their small intestine surgically removed, making it difficult for them to absorb nutrients. Tappenden has found that adding butyrate, a short-chain fatty acid, to an intravenous nutrition solution not only causes intestine to grow back but makes it more functional as well.

The research will be published as the 2004 Harry M. Vars Award paper in the July/August issue of the Journal of Parenteral and Enteral Nutrition.

"Babies born at 28 to 32 weeks sometimes develop necrotizing enterocolitis, a kind of gangrene of the intestine," said Tappenden, a professor of nutritional sciences. "Last year, 11.6 percent of births in the United States were preterm infants, and removing necrotized intestine is the most common surgical emergency in preemies.

"Surgery saves their lives, but with so much intestine removed, they're unable to digest or absorb nutrients. They can't eat by mouth like the rest of us do, and we have to use a process called total parenteral nutrition to feed them intravenously," she said.

Around 10,000 patients in the United States are totally reliant on intravenous feeding because their intestines have been surgically shortened, Tappenden said.

"Being on an IV for all a person's nutritional needs really affects his quality of life, and it puts him at risk for long-term complications, such as bone demineralization and liver failure. Many of these children eventually require organ transplants to survive. Our goal is to take kids who've had this resection and cause their gut to grow and adapt."

Tappenden said if a portion of intestine is removed, the remaining segment will grow and become more functional in an attempt to compensate for the part that's gone. "But you have to be able to feed patients orally for that change to happen, and these patients can't take food orally because they get diarrhea and other digestive issues come into play."

Tappenden became interested in modifying IV solution so that it would cause the intestine to grow the way that taking oral nutrition does. She began by adding short-chain fatty acids, acids that are reduced when dietary fiber is fermented in the colon.

"For a long time, we've known that consuming a lot of dietary fiber causes the gut to grow, so we wondered what would happen if we added fermentative products to our IV solution," she said.

She tested her hypothesis using newborn piglets, an excellent model for the human infant because it has similar metabolism and physiology.

"And not only was there more gut, the gut that was there was more functional," she said. "When we added butyrate, the villi in the intestine increased in size, and they were able to transport more nutrients."

Tappenden said feeding butyrate intravenously should cause the intestine to grow so that eventually patients won't have to rely on IVs. "But it will depend on the patient, how much intestine he has left, and where that intestine is," she said.

"We may not be able to take some patients off intravenous nutrition completely, but if patients can eat and just have one supplemental IV feeding daily, it would reduce the number of complications a great deal and increase their quality of life so much," she said.

Other researchers who contributed to the study were Anne L. Bartholome, David M. Albin, and David H. Baker, all of the University of Illinois, and Jens J. Holst of The Panum Institute, Copenhagen, Denmark.

The study was funded by the National Institutes of Health.

Contact: Phyllis Picklesimer
p-pickle@uiuc.edu
217-244-2827
University of Illinois at Urbana-Champaign

Comments

Popular posts from this blog

Is too much soy bad for men?

While soy may be beneficial to women in a variety of ways, research in monkeys suggests that it could have an adverse effect on the behavior of men, according to researchers from Wake Forest University Baptist Medical Center. Reporting in the current issue of the scientific journal Hormones and Behavior, the researchers found that in male monkeys, "long-term consumption of a diet rich in soy isoflavones can have marked influences on patterns of aggression and social behavior." Isoflavones are a naturally occurring plant estrogen in soy protein. "Although considerable attention has been directed at the potentially beneficial effects of isoflavones in reducing the risk of various cancers, osteoporosis, cardiovascular disease and postmenopausal symptoms, less effort has been invested in characterizing neurobehavioral effects," according to the study.

Myths stop women breastfeeding their babies

A survey published today by The UK Department of Health for National Breastfeeding Awareness Week (9 - 15 May) shows that serious misunderstandings may be stopping women, particularly young women, from breastfeeding. (1) Although the benefits of breastfeeding are well known (2), the UK has one of the lowest breastfeeding rates in Europe. Almost a third of women (29%) in England and Wales (3) never try to breastfeed compared to 2% in Sweden.(4) Younger women in particular are less likely to breastfeed with over 40% of mothers under 24 never trying. (3) The new survey of 1000 women shows: Myth: Over a third (34%) of women believe that modern infant formula milks are very similar or the same as breast milk Fact: Infant formula milk does not contain the antibodies, living cells, enzymes or hormones present in breastmilk. Breastmilk is designed for each individual baby and changes over time whereas infant formula milk is designed for every baby. -- Myth: A fifth (20%) of young women ...

Iron supplements help only certain women who are not anemic

Among women who are not anemic, only those with tissue-iron deficiencies can benefit from taking iron supplements, concludes a new study by Cornell University nutritionists. "Supplementation makes no difference in exercise-training improvements in women with low iron storage who are not yet tissue-iron deficient or anemic," says Thomas Brownlie, the first author of the study and a Cornell doctoral candidate in nutritional sciences. Women with low body iron, but who are not anemic, may not experience any improvements following training if their tissues are low in iron. Whereas women who have low iron storage in their liver only, and who are not anemic, appear to have no functional impairments. The study, published in theAmerican Journal of Clinical Nutrition (2004; 79:437-43), is the first to show differences between the physical abilities of nonanemic women with low-liver vs. low-tissue iron. The researchers are also the first to show that low iron without anemia does h...